Waxman Consulting, Inc.

Grant Information

• Purpose

  To (i) research and analyze anticompetitive behaviors impacting prescription drug pricing, and (ii) provide nonpartisan information and technical support to key stakeholders and policymakers.

• Grantee

  Waxman Consulting, Inc.

• Location

• Grant Amount

  $207,774

• Term

  2019 - 2020

• Funding Source

  LJAF

• Related to our work in…

  • Health
  • Drug Prices